molecular action and clinical relevance of aromatase inhibitors.  high prevalence and rising incidence: breast cancer is the most common form of cancer among women in europe, north and south america and australasia; approximately 1 in 10 women in western countries will develop breast cancer during their lifetime. it is estimated that the disease will affect five million women worldwide over the next decade, and the incidence of breast cancer is increasing on average by about 1% per year in industrialized countries and at a greater rate in developing countries.